Published in J Gen Intern Med on October 07, 2008
Sexual dysfunction in women with ESRD requiring hemodialysis. Clin J Am Soc Nephrol (2012) 1.56
Association between higher levels of sexual function, activity, and satisfaction and self-rated successful aging in older postmenopausal women. J Am Geriatr Soc (2011) 1.50
Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial. Climacteric (2014) 0.89
Sexual function in elderly women: a review of current literature. Rev Obstet Gynecol (2012) 0.87
The relationship between various psychosocial factors and physical symptoms reported during primary-care health examinations. Wien Klin Wochenschr (2010) 0.87
Childbirth and female sexual function later in life. Obstet Gynecol (2013) 0.82
Predictors of sexual well-being after endometrial cancer: results of a national self-report survey. Support Care Cancer (2014) 0.79
Sexual Satisfaction and the Importance of Sexual Health to Quality of Life Throughout the Life Course of U.S. Adults. J Sex Med (2016) 0.79
Health-related quality of life and quality of sexual life in obese subjects. Int J Endocrinol (2014) 0.78
Energy expenditure during sexual activity in young healthy couples. PLoS One (2013) 0.76
Association of sleep disturbance and sexual function in postmenopausal women. Menopause (2017) 0.75
Dissatisfaction with male sexual performance and female sexual dysfunction in women with type 1 diabetes. Int J Impot Res (2014) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
Sexual dysfunction in the United States: prevalence and predictors. JAMA (1999) 14.06
The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther (2000) 13.16
A study of sexuality and health among older adults in the United States. N Engl J Med (2007) 9.66
The Women's Health Initiative recruitment methods and results. Ann Epidemiol (2003) 8.42
The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol (2003) 7.49
Implementation of the Women's Health Initiative study design. Ann Epidemiol (2003) 7.30
Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol (2002) 5.73
Effects of estrogen plus progestin on health-related quality of life. N Engl J Med (2003) 4.83
Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res (2005) 4.61
Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch Intern Med (2004) 3.59
The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Ann Epidemiol (2003) 3.03
Sexual orientation and health: comparisons in the women's health initiative sample. Arch Fam Med (2000) 2.97
Problems with sexual function in people attending London general practitioners: cross sectional study. BMJ (2003) 2.53
Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study. Circulation (2005) 2.49
Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women's Health Across the Nation (SWAN). Menopause (2005) 2.48
Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial. Arch Intern Med (2005) 2.17
Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology (2004) 2.16
Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol (1999) 2.16
Is there an association between menopause status and sexual functioning? Menopause (2000) 1.86
Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol (2006) 1.80
The 'healthy smoker': a phenomenon of health selection? Respiration (1990) 1.75
Epidemiology/risk factors of sexual dysfunction. J Sex Med (2004) 1.70
Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction. J Sex Med (2006) 1.63
Sexual functioning and practices in a multi-ethnic study of midlife women: baseline results from SWAN. J Sex Res (2003) 1.48
Association of body weight with sexual function in women. Int J Impot Res (2007) 1.43
The GRISS: a psychometric instrument for the assessment of sexual dysfunction. Arch Sex Behav (1986) 1.36
The impact of aging on sexual function and sexual dysfunction in women: a review of population-based studies. J Sex Med (2005) 1.36
Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord (1999) 1.34
Sexual sequelae of general medical disorders. Lancet (2007) 1.29
Sexual self-schema and sexual morbidity among gynecologic cancer survivors. J Consult Clin Psychol (1997) 1.24
Sexual activity and function in postmenopausal women with heart disease. Obstet Gynecol (2005) 1.14
Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med (2006) 1.08
Predictors of angina pectoris versus myocardial infarction from the Women's Health Initiative Observational Study. Am J Cardiol (2004) 1.07
Effect of parity on sexual function: an identical twin study. Obstet Gynecol (2006) 1.07
Sexual function in well women: stratification by sexual satisfaction, hormone use, and menopause status. J Sex Med (2008) 1.05
Correlates of lesbian sexual functioning. J Womens Health (Larchmt) (2007) 1.02
Sexual dysfunction: overview of prevalence, etiological factors, and treatments. J Sex Res (2002) 1.02
An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer. Int J Gynecol Cancer (2006) 1.02
Sexual dysfunction in women: population based epidemiological study. Arch Womens Ment Health (2002) 0.99
Differential effects of sympathetic activation on sexual arousal in sexually dysfunctional and functional women. J Abnorm Psychol (1996) 0.98
The effect of mode of delivery, parity, and birth weight on risk of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.98
Women's sexual dysfunction: a pathophysiological review. BJU Int (2004) 0.97
Confronting the challenges: epidemiological study of female sexual dysfunction and the menopause. J Sex Med (2005) 0.97
Sex in Australia: autoerotic, esoteric and other sexual practices engaged in by a representative sample of adults. Aust N Z J Public Health (2003) 0.96
Clinical biologic pathophysiologies of women's sexual dysfunction. J Sex Med (2005) 0.94
Sexuality and the menopause. J Psychosom Obstet Gynaecol (1994) 0.94
Ecological models of sexual satisfaction among lesbian/bisexual and heterosexual women. Arch Sex Behav (2008) 0.90
Modeling mid-aged women's sexual functioning: a prospective, population-based study. J Sex Marital Ther (2004) 0.89
Women, alcohol, and sexuality. Adv Alcohol Subst Abuse (1984) 0.89
The effects of postmenopausal hormone therapies on female sexual functioning: a review of double-blind, randomized controlled trials. Menopause (2004) 0.87
The effect of hysterectomy on sexual functioning. Annu Rev Sex Res (2003) 0.86
Depression and sexual functioning in minority women: current status and future directions. J Sex Marital Ther (2005) 0.84
Menopausal Sexual Interest Questionnaire (MSIQ): a unidimensional scale for the assessment of sexual interest in postmenopausal women. J Sex Marital Ther (2004) 0.83
Sexual dysfunction secondary to depressive disorders. J Gend Specif Med (2001) 0.80
SSRI sexual dysfunction: a female perspective. J Sex Marital Ther (2002) 0.78
Sexual dissatisfaction of female alcoholics. Psychol Rep (1984) 0.77
Risk factors for surgically managed pelvic organ prolapse and urinary incontinence. Int J Gynaecol Obstet (2007) 0.77
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med (2005) 15.18
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09
Estrogen therapy and coronary-artery calcification. N Engl J Med (2007) 8.70
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology (2008) 6.87
Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc (2005) 6.73
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med (2012) 6.46
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med (2006) 6.14
Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol (2009) 5.59
Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med (2005) 5.49
Effects of estrogen with and without progestin on urinary incontinence. JAMA (2005) 5.41
Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol (2008) 5.28
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes (2002) 4.97
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care (2006) 4.62
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA (2007) 4.36
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16
Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer (2007) 3.96
Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med (2006) 3.91
Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA (2012) 3.66
Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr (2005) 3.55
Evidence-based guidelines for cardiovascular disease prevention in women. Circulation (2004) 3.39
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am J Epidemiol (2009) 3.33
Oral bisphosphonate use and breast cancer incidence in postmenopausal women. J Clin Oncol (2010) 3.17
Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation (2006) 3.11
Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study. Obstet Gynecol (2013) 3.08
Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care (2006) 3.06
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. Am J Epidemiol (2008) 3.05
The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Ann Epidemiol (2003) 3.03
Sexual orientation, health risk factors, and physical functioning in the Nurses' Health Study II. J Womens Health (Larchmt) (2004) 3.01
The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). J Am Coll Cardiol (2010) 2.96
Performance-based measures of physical function for high-function populations. J Am Geriatr Soc (2006) 2.95
Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA (2003) 2.90
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89
Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials. Arch Intern Med (2010) 2.89
Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann Surg (2010) 2.80
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. Am J Epidemiol (2008) 2.79
Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) (2006) 2.77
Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol (2008) 2.74
Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation (2005) 2.73
Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med (2009) 2.72
Retracted Implications of new hypertension guidelines in the United States. Hypertension (2011) 2.58
A randomized comparison of total or supracervical hysterectomy: surgical complications and clinical outcomes. Obstet Gynecol (2003) 2.57
Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial. Menopause (2010) 2.50
The Women's Health Initiative: The food environment, neighborhood socioeconomic status, BMI, and blood pressure. Obesity (Silver Spring) (2011) 2.50
Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation (2007) 2.50
Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study. Circulation (2005) 2.49
Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. Hypertension (2008) 2.44
Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes (2012) 2.43
Abdominal aortic aneurysm events in the women's health initiative: cohort study. BMJ (2008) 2.41
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors. Circulation (2009) 2.41
Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab (2002) 2.40
Dietary intake among youth with diabetes: the SEARCH for Diabetes in Youth Study. J Am Diet Assoc (2006) 2.35
Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J Clin Endocrinol Metab (2006) 2.34
Effects of prescription nonsteroidal antiinflammatory drugs on symptoms and disease progression among patients with knee osteoarthritis. Arthritis Rheumatol (2015) 2.34
Multimarker prediction of coronary heart disease risk: the Women's Health Initiative. J Am Coll Cardiol (2010) 2.34
Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study. Diabetes Care (2007) 2.33
Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA (2008) 2.32
Symptom experience after discontinuing use of estrogen plus progestin. JAMA (2005) 2.32
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2014) 2.30
Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis (2005) 2.30
Calcium and vitamin D supplementation and cognitive impairment in the women's health initiative. J Am Geriatr Soc (2012) 2.30
Sugar-sweetened beverage, sugar intake of individuals, and their blood pressure: international study of macro/micronutrients and blood pressure. Hypertension (2011) 2.29
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol (2007) 2.26
The Lifestyle Interventions and Independence for Elders Study: design and methods. J Gerontol A Biol Sci Med Sci (2011) 2.26
C-reactive protein in the prediction of rheumatoid arthritis in women. Arch Intern Med (2006) 2.22
Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes (2007) 2.19
Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum (2009) 2.19
A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care (2006) 2.18
Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned. Circulation (2002) 2.18
Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative. Circulation (2012) 2.17
Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study. PLoS Genet (2011) 2.13